Please use this identifier to cite or link to this item:
|Title:||Runx3 is required for full activation of regulatory T cells to prevent colitis-associated tumor formation|
|Citation:||Sugai, M., Aoki, K., Osato, M., Nambu, Y., Ito, K., Taketo, M.M., Shimizu, A. (2011-06-01). Runx3 is required for full activation of regulatory T cells to prevent colitis-associated tumor formation. Journal of Immunology 186 (11) : 6515-6520. ScholarBank@NUS Repository. https://doi.org/10.4049/jimmunol.1001671|
|Abstract:||Inflammation is increasingly recognized as an essential component of tumorigenesis, which is promoted and suppressed by various T cell subsets acting in different ways. It was shown previously in Runx3-deficient mice that differentiation of CD8 Tand NK cells is perturbed. In this study, we show that Runx3 is also required for proper differentiation and function of regulatory T cells. In Runx3-deficient mice, T cells were unable to inhibit inflammation and to suppress tumor development. As expected, recombination activating gene 2-deficient mice bearing Runx3-deficient lymphocytes spontaneously developed colon tumors. However, tumor formation was completely blocked by transfer of either regulatory T cells or CD8 T cells derived from wild-type mice to mutant mice or by housing mutant mice in a specific pathogen-free condition. These results indicate that Runx3-deficient lymphocytes and microorganisms act together to induce inflammation and consequently induce the development of colon tumors. Copyright © 2011 by The American Association of Immunologists, Inc.|
|Source Title:||Journal of Immunology|
|Appears in Collections:||Staff Publications|
Show full item record
Files in This Item:
There are no files associated with this item.
checked on Jun 22, 2018
WEB OF SCIENCETM
checked on May 23, 2018
checked on May 4, 2018
Items in DSpace are protected by copyright, with all rights reserved, unless otherwise indicated.